Boston Scientific Announces FDA Approval Of New Leads For The Precision Plus™ Spinal Cord Stimulator System
Source: Medical News Today
Friday 30th July, 2010
Boston Scientific Corporation (NYSE: BSX) announced U.S. Food and Drug Administration approval of two spinal cord stimulation (SCS) leads for use with its Precision Plus™ Spinal Cord Stimulator ... ...
Read the full story at
Medical News Today
Email this story to a friend
Have your say on this story
